Neonav® ECG Tip Location System Received FDA 510(k) Clearance to Improve Pediatric Vascular Access Care
On February 16, 2025, Navi Medical Technologies, a leader in pediatric healthcare innovation, announced that its Neonav® ECG Tip Location System received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance enables the system's deployment in U.S. hospitals, marking a significant advancement in pediatric vascular access care.
The Neonav® ECG tip location system is the first and only device specifically designed for neonatal and pediatric patients. Utilizing real-time ECG signal analysis, the system ensures precise placement of...